These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 20432444

  • 1. Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway.
    Huang CY, Lee CY, Chen MY, Tsai HC, Hsu HC, Tang CH.
    J Cell Physiol; 2010 Aug; 224(2):475-83. PubMed ID: 20432444
    [Abstract] [Full Text] [Related]

  • 2. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways.
    Tang CH, Lu ME.
    Prostate; 2009 Dec 01; 69(16):1781-9. PubMed ID: 19676095
    [Abstract] [Full Text] [Related]

  • 3. Adiponectin increases MMP-3 expression in human chondrocytes through AdipoR1 signaling pathway.
    Tong KM, Chen CP, Huang KC, Shieh DC, Cheng HC, Tzeng CY, Chen KH, Chiu YC, Tang CH.
    J Cell Biochem; 2011 May 01; 112(5):1431-40. PubMed ID: 21321996
    [Abstract] [Full Text] [Related]

  • 4. Involvement of AdipoR receptor in adiponectin-induced motility and alpha2beta1 integrin upregulation in human chondrosarcoma cells.
    Chiu YC, Shieh DC, Tong KM, Chen CP, Huang KC, Chen PC, Fong YC, Hsu HC, Tang CH.
    Carcinogenesis; 2009 Oct 01; 30(10):1651-9. PubMed ID: 19549705
    [Abstract] [Full Text] [Related]

  • 5. Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts.
    Tseng WP, Yang SN, Lai CH, Tang CH.
    J Cell Physiol; 2010 Jun 01; 223(3):810-8. PubMed ID: 20232298
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
    Tang CH, Yang RS, Chien MY, Chen CC, Fu WM.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):40-9. PubMed ID: 17980360
    [Abstract] [Full Text] [Related]

  • 7. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
    Wu JB, Fong YC, Tsai HY, Chen YF, Tsuzuki M, Tang CH.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):333-41. PubMed ID: 18495116
    [Abstract] [Full Text] [Related]

  • 8. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
    Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY.
    J Bone Miner Res; 2006 Oct 07; 21(10):1648-56. PubMed ID: 16995820
    [Abstract] [Full Text] [Related]

  • 9. Involvement of p38MAPK/NF-κB signaling pathways in osteoblasts differentiation in response to mechanical stretch.
    Wang L, Li JY, Zhang XZ, Liu L, Wan ZM, Li RX, Guo Y.
    Ann Biomed Eng; 2012 Sep 07; 40(9):1884-94. PubMed ID: 22441665
    [Abstract] [Full Text] [Related]

  • 10. M-Ras is activated by bone morphogenetic protein-2 and participates in osteoblastic determination, differentiation, and transdifferentiation.
    Watanabe-Takano H, Takano K, Keduka E, Endo T.
    Exp Cell Res; 2010 Feb 01; 316(3):477-90. PubMed ID: 19800879
    [Abstract] [Full Text] [Related]

  • 11. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
    Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT.
    J Bone Miner Res; 2002 Jan 01; 17(1):101-10. PubMed ID: 11771655
    [Abstract] [Full Text] [Related]

  • 12. Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells.
    Lee HW, Kim SY, Kim AY, Lee EJ, Choi JY, Kim JB.
    Stem Cells; 2009 Sep 01; 27(9):2254-62. PubMed ID: 19522015
    [Abstract] [Full Text] [Related]

  • 13. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
    Kuo PL, Hsu YL, Chang CH, Chang JK.
    J Pharmacol Exp Ther; 2005 Sep 01; 314(3):1290-9. PubMed ID: 15956019
    [Abstract] [Full Text] [Related]

  • 14. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway.
    Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, Liao EY.
    Exp Cell Res; 2005 Sep 10; 309(1):99-109. PubMed ID: 15963981
    [Abstract] [Full Text] [Related]

  • 15. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y, Koike T, Ohta Y, Manaka T, Imai Y, Takaoka K.
    Bone; 2009 May 10; 44(5):872-7. PubMed ID: 19442611
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
    Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB.
    Diabetes; 2006 Sep 10; 55(9):2562-70. PubMed ID: 16936205
    [Abstract] [Full Text] [Related]

  • 17. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN.
    J Bone Miner Res; 2007 May 10; 22(5):646-55. PubMed ID: 17266397
    [Abstract] [Full Text] [Related]

  • 18. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, Goto J, Yamamura M, Makino H.
    J Endocrinol; 2008 Mar 10; 196(3):601-13. PubMed ID: 18310456
    [Abstract] [Full Text] [Related]

  • 19. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
    Lai TH, Fong YC, Fu WM, Yang RS, Tang CH.
    Prostate; 2008 Sep 01; 68(12):1341-53. PubMed ID: 18512729
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone upregulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells.
    Takase H, Yano S, Yamaguchi T, Kanazawa I, Hayashi K, Yamamoto M, Yamauchi M, Sugimoto T.
    Horm Metab Res; 2009 Dec 01; 41(12):861-5. PubMed ID: 19672814
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.